EYDIS BIO, INC.

Search SAM.gov-registered contractors by mission sector, compliance posture and contract vehicle.

Mission sectors

Live demo

Arclight Demo Aerospace & Defense, Inc.

UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate

CMMC Level 2 (C3PAO)
6 contract vehicles
Case studies & key people
Photo gallery & brand

See the finished profile Download it as an AI-ready Markdown file

A fictional company, built to show every section filled in.

Looking for something specific? Tour the demo profile

Open solicitations, teaming requests and recompetes, from SAM.gov and USAspending.

Pipeline

Popular vehicles

Try an example search

Real filters on live federal data. One click opens the results.

Looking for something specific? Tour the demo profile

AI capture analysis, capability statement grading and plain-language guides.

Analyze

Learn

Ask the AI Capture Analyst

Teaming analysis, best-fit partners, RFP fit and compliance matrices, grounded in TeamingIndex data.

Open the Intelligence Hub Grade a capability statementFree score in seconds. The PDF is never stored.

Looking for something specific? Tour the demo profile

Teaming agreements and proposals, plus how TeamingIndex verifies, protects and connects your data.

Product

Trust

Claim your company, free

Verify your UEI with your work email and control how primes see you. Every badge shows who vouches for it and when.

Claim your profile

Your workspace

Profile, compliance, team, saved searches and billing.

Go to your dashboard

Compare plans

Looking for something specific? Tour the demo profile

See TeamingIndex with real data before you sign up: a finished profile and working searches.

Sample pages

Example searches

Live demo

Arclight Demo Aerospace & Defense, Inc.

UEI DEMOPRIMEC01 · CAGE 0DEMO · Prime Corporate

CMMC Level 2 (C3PAO)
6 contract vehicles
Case studies & key people
Photo gallery & brand

See the finished profile Download it as an AI-ready Markdown file

A fictional company, built to show every section filled in.

Looking for something specific? Tour the demo profile

Popular

See it with data

EYDIS BIO, INC. — UEI MWWCM7JMBCF1 | TeamingIndex

Proven teaming graph

Learn more

Who EYDIS BIO, INC. has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.

See where agencies spend

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

SBIR/STTR portfolio

Learn more About SBIR/STTR

Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects

Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.

Awards on record: 7 awards
Total awarded: $6,615,113
By phase: SBIR Phase I: 3
SBIR Phase II: 2

FedRAMP offerings

Learn more

Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.

Find FedRAMP-authorized companies

Source: FedRAMP Marketplace · sync date not recorded

Exclusions & screening

Exclusions Screening list

Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

GSA CALC+ rate benchmark

Learn more

Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.

See GSA MAS holders

Source: GSA CALC+ awarded ceiling rates · sync date not recorded

Awards (most recent first)

Development of selective NS5 inhibitors for the broad-spectrum treatment of flaviviruses
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $499,825
Solicitation PHS 2025-1 (2025) · Topic 146
Development of orally bioavailable and blood-brain barrier penetrant, small molecule TAK1 inhibitors as a novel treatment for Alzheimer's Disease
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $506,267
Sep 15, 2024 – May 31, 2025
Solicitation PAS22-197 (2022) · Topic NIA · Research partner: NORTH CAROLINA STATE UNIVERSITY RALEIGH
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $2,600,290
Jul 15, 2024 – Jun 30, 2026
Solicitation PA23-230 (2023) · Topic NHLBI
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,709,883
Sep 22, 2021 – Aug 31, 2023
Solicitation PA20-260 (2020) · Topic NIAMS
Evaluating the Blood-Brain Barrier Bioavailability and in vivo Efficacy Potential of a Novel TAK1 Inhibitor Targeting Chronic Pain
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $480,955
Sep 8, 2021 – Aug 31, 2022
Solicitation NS20-011 (2020) · Topic NINDS
Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $593,995
Aug 1, 2021 – May 31, 2023
Solicitation PA19-272 (2019) · Topic NHLBI
Improving the Oral Bioavailability and In vivo Efficacy of a Novel TAK1 Inhibitor Targeting Rheumatoid Arthritis
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $223,898
Sep 18, 2019 – Aug 31, 2020
Solicitation PA18-575 (2018) · Topic NIAMS · Research partner: DUKE UNIVERSITY

Compliance posture: unverified (SAM.gov baseline only)

About EYDIS BIO, INC.

Identifiers

Ready to team with EYDIS BIO, INC.?

Capabilities & differentiators

Compliance posture

Facility clearance

Past performance

Contract vehicles

Proven teaming graph

SBIR/STTR portfolio

FedRAMP offerings

Exclusions & screening

SAM.gov exclusions

GSA CALC+ rate benchmark

NAICS, PSC & socio-economic status

Teaming preferences

Business development contact

Corporate hierarchy

Data sources & provenance

Consolidated Screening List